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Background: After the initial subarachnoid hemorrhage (SAH), rebleeding is the major 
cause of morbidity and poor outcome, which is maximal in the first 24 h. We supposed 
that the coiling of ruptured intracranial aneurysms within 24 h of SAH is related to the 
improved clinical outcome compared with coiling 24 h after aneurysmal SAH.
Objective: We examined whether coiling ruptured aneurysms within 24 h of aneurysmal 
SAH is associated with better early 24 h and late 30 days outcome.
Method: This prospective study was carried on 30 patients with aneurysmal SAH 
presenting to the Alexandria University Hospital and Insurance Main Hospital during the 
period from February 2013 to May 2014. They were divided into two groups: Group I (10 
patients treated within 24 h of presentation) and Group II (20 patients treated after 24 h 
of presentation). Time interval from presentation to treatment were 78.60 and 10.60 h for 
subacute and hyperacute group, respectively. All patients were treated with endovascu-
lar coiling. Change between admission and immediate postoperative World Federation 
of Neurosurgeons classification Scale was measured for early outcome, while remote 
outcome was measured by modified Rankin Scale at 30 days follow-up.
results: There was a clinical improvement regarding early 24  h outcome (weighted 
by postoperative WFNS grade) and on late 30 days outcome (weighted by Modified 
Rankin Scale Score) in the group managed within 24 h versus who were treated after 
24 h (P = 0.049 and P = 0.024, respectively). There was a significant decrease in the 
incidence of clinical rebleeding detected by postoperative computed tomography (CT) of 
the brain in patients undergoing aneurysm treatment within 24 h (P = 0.029).
conclusion: The study affirms evidence that the management of ruptured intracranial 
aneurysms within 24  h of SAH is associated with better immediate and short-term 
clinical outcome.
Keywords: subarachnoid hemorrhage, endovascular treatment, aneurysm, timing, outcome
Abbreviations: SAH, subarachnoid hemorrhage; WFNS, World Federation of Neurosurgeons classification Scale.
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inTrODUcTiOn
Aneurysmal subarachnoid hemorrhage (SAH) is a subset of 
stroke that occurs at a relatively young age (median 55 years) and 
has a high rate of morbidity (25%) and case fatality (35%). In SAH 
patients who survive the first few days after bleeding, rebleeding 
is an important contributor to poor outcome (1).
For the last two decades, there has been proof that most 
rebleeds occur during the first 24 h after SAH. Multiple studies 
have proven that the incidence of rebleeding is maximal during 
the first 24 h after SAH with rates of 4.1–17.3% reported (2). Most 
studies reporting outcomes associated with rebleeding within 
24  h have demonstrated case-fatality rates approaching 65%, 
some as high as 80%, and incidences of 10% (3).
The time interval from presentation to management of acutely 
ruptured aneurysms (endovascular coiling) has been the issue 
of considerable debate (2). Earlier treatment of the ruptured 
intracranial aneurysm is associated with the lower incidence of 
rebleeding but was historically considered as a higher risk than a 
delayed management (4).
Few studies analyzed the management of ruptured aneu-
rysms within 24 h of SAH, most of them were in retrospective 
manner not prospective one like our study (5). Also, most 
of them were comparing any intervention (both surgery and 
endovascular coiling) in addition to defining early treatment 
at the first 72  h after SAH, unlike our study. To date, not 
enough published data are present that compare hyperacute 
treatment (within 24  h of aneurysmal SAH) with treatment 
at more than 24 h post-SAH (6). We believe that our work is 
somewhat novel.
We supposed that coiling of ruptured intracranial aneurysms 
within 24 h of SAH is related to improved clinical outcome com-
pared with coiling 24 h after aneurysmal SAH.
MaTerials anD MeThODs
subject
This study was carried out among patients with SAH present-
ing to the Alexandria University Hospital and Insurance Main 
Hospital during the period from February 2013 to May 2014. 
The study consisted of 30 patients with aneurysmal SAH 
divided into two groups: Group I: study group (10 patients); 
hyperacute aneurysmal SAH referred for coiling and treated 
within 24 h from presentation and Group II: study group (20 
patients); subacute aneurysmal SAH referred for coiling and 
treated after 24  h from presentation. All patients underwent 
clinical evaluation that include personal data, medical data, 
past medical history, social history, and complete clinical 
neurological examination. Early 24  h outcome was measured 
by World Federation of Neurosurgeons classification Scale (7) 
at 24 h postoperatively, and late 30 days outcome was measured 
by the modified Rankin Scale at 30 days follow-up by contacting 
the participants by telephone and arranging an interview (8). 
Rebleeding was detected by an increase of Fisher grade through 
evidence of blood in the subarachnoid space, ventricular system, 
or brain parenchyma by follow-up computed tomography (CT). 
Rebleeding may be symptomatic [associated with acute clinical 
deterioration (decrease of one or more grade on Glasgow Coma 
Score) and confirmed by repetitive CT scan] or asymptomatic 
[confirmed by repetitive CT scan only]. Pre endovascular 
evaluation included CT of the brain, CT angiography, and ini-
tial diagnostic subtraction angiography (DSA). All the ethical 
committee data and request are included, including the consent 
from all patients.
Procedure
The endovascular treatment was started by puncture of the femo-
ral artery, followed by introducing the guide-catheter (6F) to be 
positioned in the cervical vessel that allows access to the aneurysm. 
Angiographic assessment by a rotational angiographic data set to 
obtain 3D reconstruction of the aneurysm. We started with pos-
sible largest coil then smaller one and so on, under fluoroscopic 
roadmap guidance, to serves framing the theoretical boundary 
of the aneurysm (framing coil). Appropriately sized smaller coils 
were subsequently delivered to fill the aneurysm fundus, anti-
coagulation with intravenous heparin, or heparinization during 
treatment was employed. In some cases, we used simple coiling 
while in other cases where simple coiling is impossible, we used 
adjunctive endovascular maneuvers (assisted coiling) that involve 
the one of the following:
 a. Remodeling of the neck (neck selective technique), in case of 
wide neck, such as:
 i. Balloon-assisted coiling
 ii. Stent-assisted coiling
 b. Remodeling of the sac (branch selective technique), such as 
catheter-assisted catheter technique.
Endovascular treatment to all patients and validation of data in 
terms of angiographic findings and treatment efficacy were done 
by consultant neuro-interventionist, Osama Yassin Mansour. 
Outcome assessment was done by the corresponding author and 
reviewed by the other two authors.
Postoperative Management
The treatment of vasospasm was managed by Triple-H therapy 
(induced hypertension, hypervolemia, and hemodilution) and 
endoluminal angioplasty. Post-endovascular evaluation included 
postoperative CT of the brain to exclude any postoperative com-
plications (intra-cerebral and/or intra-ventricular hemorrhage, 
brain oedema, or cerebral infarction).
Our policy is to manage all cases within 24 h of aneurys-
mal SAH. Management delays were due to the transfer from 
other hospitals or from rural areas, hospital logistical delays 
(access to operating rooms and nursing staff ), and delayed 
diagnoses.
The study protocol was reviewed and approved by data safety 
monitoring board and subsequently by the local institutional 
review board. Each patient or his relative signed a written 
informed consent before the procedure. Relevant data were 
recorded on a standard case reporting form.
Data were fed to the computer and analyzed using IBM SPSS 
software package version 20.0. The distributions of quantitative 
TaBle 2 | comparison between the two studied groups as regards 
outcome.
subacute group  
(after 24 h,  
20 patients)
hyperacute group  
(within 24 h,  
10 patients)
P value
Early 24 h outcome 0.019*
 Better outcome 6 (30) 8 (80)
  Worse outcome or no 
change
14 (70) 2 (20)
Late 30 days outcome 0.024*
 Good outcome 9 (45) 9 (90)
 High morbidity 10 (50) 1 (10)
*P value ≤0.05.
TaBle 1 | comparison between the two studied groups as regards 
demographic data and risk factors.
subacute group  
(after 24 h,  
20 patients)
hyperacute group  
(within 24 h,  
10 patients)
P value
Age 50.65 ± 12.40 50.50 ± 15.81 0.977
Female 12 (60) 3 (30) 0.121
HTN 13 (65) 7 (70) 1.000
DM 4 (20) 3 (30) 0.657
WFNS grade (admission 
grade)
0.313
1 9 (45) 2 (20)
2 5 (25) 4 (40)
3 3 (15) 4 (40)
4 2 (10) 0 (0)
5 1 (5) 0 (0)
Mortality 1 (5) 0 (0)
Size (mm) 1.000
Less than 7 11 (55) 6 (60)
7–12 8 (40) 4 (40)
13–24 1 (5) 0 (0)
More than 25 0 (0) 0 (0)
Location 1.000
Anterior circulation 14 (70) 7 (70)
ICA 3 (15) 1 (10)
ACOM 6 (30) 5 (50)
ACA 1 (5) 1 (10)
MCA 4 (20) 0 (0)
Posterior circulation 6 (30) 3 (30)
BA 4 (20) 1 (10)
PCOM 1 (5) 1 (10)
PCA 0 (0) 1 (10)
PICA 1 (5) 0 (0)
TaBle 3 | comparison between the two studied groups as regards to the 
incidence of rebleeding.
subacute group 
(after 24 h,  
10 patients)
hyperacute group 
(within 24 h,  
10 patients)
P value
Symptomatic rebleeding 8 (40) 0 (0) 0.029*
*P ≤ 0.05.
TaBle 4 | comparison between the two studied groups as regards to 
time interval from presentation to treatment.
subacute group  
(after 24 h,  
10 patients)
hyperacute group  
(within 24 h,  
10 patients)
t P value
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variables were tested for normality using Kolmogorov–Shapiro–
Wilk test and D’Agstino test, also Histogram and QQ plot were 
used for vision test. For normally distributed data, comparison 
between two independent populations was done using inde-
pendent t-test. Significance of the obtained results was judged 
at the 5% level.
resUlTs
Statistical analysis demonstrated no significant difference in 
age, gender, hypertension, diabetes mellitus, admission grade, 
size, and location between those managed within 24 h (hypera-
cute) and those managed after 24 h (subacute). We had only one 
patient who died during the follow-up in the subacute group 
(Table 1).
Early 24  h outcome was measured by clinical improvement 
weighted by reduction in WFNS grade (≥1 grade). In the hypera-
cute group,; there were eight patients (80%) who were clinically 
improved, compared to six patients (30%) in the subacute group 
with statistical significant difference between both groups 
(P = 0.019) (Table 2).
Dichotomization of the mRS outcome data into good outcome 
(mRS 0–2) and high morbidity (mRS 3–5) also demonstrated a 
statistical significant difference. The patients were followed up 
for a mean of 31 days (range between 26 and 34 days). Also, 90% 
(n = 9) of cases in hyperacute group achieved a good outcome 
(mRS 0–2) on late 30 days follow-up, while only 45% (n = 9) 
of cases of subacute group achieved a good outcome with sta-
tistical significant difference between both groups (P = 0.024) 
(Table 2).
Rebleeding was present in 40% (n = 8) of cases in subacute 
group only. Statistically significant decrease in incidence in 
clinical rebleeding detected by postoperative CT of the brain was 
observed in patients undergoing aneurysm treatment within 24 h 
(0 versus 40%, P = 0.029) (Table 3).
Time interval from presentation to treatment was signifi-
cantly higher in subacute group compared to hyperacute group 
(P = 0.0001), wherein the subacute group, the mean time interval 
from presentation to treatment was 78.60 versus 10.0  h in the 
hyperacute group (Table 4).
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DiscUssiOn
The time interval from presentation to management of acutely 
ruptured aneurysms (endovascular coiling) has been the issue 
of considerable debate (2). Definitions have been developed 
for specific time intervals that have been considered better or 
worse options during the last half century. Late treatment usu-
ally points to 10 days post-SAH; intermediate treatment points 
to days 4–10; early treatment points to the first 3  days; and 
ultra-early treatment points to surgery during the first 24 h. We 
point to all treatment after the first 24 h as delayed, a group that 
included the previously mentioned early, intermediate, and late 
treatment (9).
After the initial SAH, rebleeding is the major cause of morbid-
ity and poor outcome (10, 11). Among aneurysms that rebleed, 
approximately 20% do so in the first 2 weeks, 30% by the end of the 
first month, and 40% by the end of 6 months. Beyond 6 months, 
rerupture occurs at a rate of approximately 3% per year (12). No 
infallible rules predict which patients will have recurrent hemor-
rhages (13). Most studies reporting outcomes associated with 
rebleeding within the first 24 h have demonstrated case-fatality 
rates approaching 65%, some as high as 80%, and incidences of 
10% (3).
Securing the ruptured intracranial aneurysm within the first 
24 h after SAH has showed reduction in the risk of rebleeding. 
Earlier coiling of the ruptured aneurysm also means that medical 
or endovascular management for vasospasm/delayed ischemic 
neurological deficits can be initiated instantly (14).
In our cohort, 80% (n  =  8) of cases of hyperacute group 
achieved a better outcome on early 24 h follow-up compared to 
30% (n = 6) of cases of subacute group with statistical significant 
difference between both groups (P = 0.019). Our findings were in 
consistence with a retrospective 11-year single-center study done 
by Phillips et al., who suggested that treatment within 24 h was 
related to a better neurological outcome (15). Our findings are 
also in consistence with Bergui and Bradac, who reviewed the 
outcome of 45 consecutive patients treated acutely by coiling after 
SAH and found that about half had a favorable outcome; a prom-
ising result in accordance with some surgical and endovascular 
reports proposing early aggressive treatment of an aneurysm 
causing SAH (16). These findings are also in agreement with a 
study done by Wong et al., who reported that treatment within 
24  h is associated with better clinical outcomes of aneurysmal 
SAH, as less clinical rebleeding happens. The same study reported 
that aneurysm treatment carried out within the 24 h may improve 
clinical outcome and halve the clinical rebleeding in poor-grade 
SAH patients (17).
In the present cohort, 90% (n = 9) of cases in hyperacute group 
achieved a good outcome (mRS 0–2) on late 30 days follow-up, 
while only 45% (n =  9) of cases in subacute group achieved a 
good outcome with statistical significant difference between both 
groups (P =  0.024). The mortality in our patients (5%, n =  1) 
was more or less similar to that of the patients in the ISAT study 
(8.1%), this can be partially explained by the fact that the higher 
prevalence of patients with milder clinical presentation, WFNS 
grades (1 and 2), in both cohorts (70% of patients in our study 
and 88% of patients in the ISAT study) (18).
Regarding low prevalence of grades 4 and 5 (0%, n =  1) in 
group of patients treated within 24  h, which was due to small 
number enrolled during study period, we think that it is a good 
chance that shows the true real practice, where those higher grade 
patients with higher possibility of having ICH or IVH are pre-
ferred to be managed with open surgery to additionally evacuate 
ICH or to deploy shunting for CSF.
In our cohort, symptomatic rebleeding was present in 40% 
(n =  8) of cases in subacute group only, all of the rebleeding 
cases had hypertension while six out of eight had poor admission 
grade (WFNS grade 3 or 4), which can explain the occurrence of 
rebleeding among these cases. Statistically significant decrease in 
incidence of clinical rebleeding was observed in patients under-
going aneurysm treatment within 24 h (0 versus 40%, P = 0.029). 
These findings could be explained by significant longer door 
to puncture time interval in subacute group when compared 
to hyperacute group (p = 0.0001). In 2001, Ohkuma et al. (19) 
examined 273 patients who were admitted to their institution 
within 24  h after the initial SAH bleeding and recorded that 
13.6% of patients with SAH suffered rebleeding in the ambulance 
or before admission to the referring hospital, which was related 
to systolic arterial pressure >160 mmHg. Our result went also in 
agreement with Guo et al., who showed that rebleeding found in 
24 patients (34.3%) within 3 h compared to 44 patients (62.9%) 
within 6 h with aneurysm size and systolic arterial pressure were 
the independent risk factors for aneurysmal rebleeding (20). In 
other study, Tanno et  al. reported that rebleeding occurs more 
frequently in the earlier period after the initial SAH than previ-
ously believed and found that rebleeding occurred in 65 patients 
(35.9%) within 3 h and 88 patients (48.6%) within 6 h after the 
initial SAH, which was not related to hypertension, as systolic 
arterial blood pressure prior to rebleeding was most common 
between 120 and 140 mmHg (4).
The primary limitation of this study is the way of enrollment 
of our cases, which was based on availability of cases and not on 
randomization. The present study was also limited by the small 
sample size that may be due to the narrow time frame of the study. 
This may shed light on the real practice behavior of referring such 
patients at least in our region that needs to be changed, so further 
study with larger sample size is required to confirm the findings.
cOnclUsiOn
Aneurysm treatment within 24 h may be associated with better 
clinical outcome. The study affirms evidence that management of 
ruptured intracranial aneurysms within 24 h of SAH is associated 
with better immediate and short-term clinical outcome.
aUThOr cOnTriBUTiOns
All authors listed have made substantial, direct, and intellectual 
contribution to the work and approved it for publication.
5Ibrahim Ali et al. Hyperacute Coiling of Aneurysmal Subarachnoid Hemorrhage
Frontiers in Neurology | www.frontiersin.org June 2016 | Volume 7 | Article 79
reFerences
1. Nieuwkamp DJ, Setz LE, Algra A, Linn FH, Rooij NK, Rinkel GJ. Changes in case 
fatality of aneurysmal subarachnoid haemorrhage over time, according to age, 
sex, and region: a meta-analysis. Lancet Neurol (2009) 8:635–42. doi:10.1016/ 
S1474-4422(09)70126-7 
2. Cha K, Kim J, Kang H, Moon B, Lee S, Kim J. Aneurysmal rebleeding: factors 
associated with clinical outcome in the rebleeding patients. J Korean Neurosurg 
Soc (2010) 47:119. doi:10.3340/jkns.2010.47.2.119 
3. Rosenorn J, Eskesen V, Schmidt K, Ronde F. The risk of rebleeding from 
ruptured intracranial aneurysms. J Neurosurg (2009) 67:329–32. doi:10.3171/
jns.1987.67.3.0329 
4. Tanno Y, Homma M, Oinuma M, Kodama N, Ymamoto T. Rebleeding from 
ruptured intracranial aneurysms in north eastern province of Japan. A 
cooperative study. J Neurol Sci (2007) 258:11–6. doi:10.1016/j.jns.2007.01.074 
5. Laidlaw J, Siu K. Ultra-early surgery for aneurysmal subarachnoid hemor-
rhage: outcomes for a consecutive series of 391 patients not selected by grade 
or age. J Neurosurg (2002) 97:250–8. doi:10.3171/jns.2002.97.2.0250 
6. Lawson MF, Chi Y-Y, Velat GJ, Mocco JD, Hoh BL. Timing of aneurysm 
surgery: the international cooperative study revisited in the era of endo-
vascular coiling. J Neurointerv Surg (2010) 2:131–4. doi:10.1136/jnis.2009. 
001172 
7. Teasdale GM, Drake CG, Hunt W, Kassell N, Sano K, Pertuiset B, et al. A uni-
versal subarachnoid hemorrhage scale: report of a committee of the World 
Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry (1988) 
51(11):1457. doi:10.1136/jnnp.51.11.1457 
8. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver 
agreement for the assessment of handicap in stroke patients. Stroke (1988) 
19:604–7. doi:10.1161/01.STR.19.5.604 
9. Jagt MVD, Hasan D, Dippel DWJ, Dijk EJV, Avezaat CJJ, Koudstaal PJ. Impact 
of early surgery after aneurysmal subarachnoid haemorrhage. Acta Neurol 
Scand (2009) 119:100–6. doi:10.1111/j.1600-0404.2008.01064.x 
10. Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE, Diringer MN, 
et al. Guidelines for the management of aneurismal subarachnoid hemorrhage: 
a statement for healthcare professionals from a special writing group of the 
stroke council, American Heart Association. Stroke (2009) 40(3):994–1025. 
doi:10.1161/STROKEAHA.108.191395
11. Weyer GW, Nolan CP, Macdonald RL. Evidence-based cerebral 
vasospasm management. Neurosurg Focus (2006) 21:8. doi:10.3171/foc.2006. 
21.3.8 
12. Parkarinen S. Incidence, etiology, and prognosis of primary subarachnoid 
hemorrhage: a study based on 589 cases diagnosed in a defined urban popu-
lation during a defined period. Acta Neurol Scand (1967) 43(29):1–128. 
13. Locksley HB. Report of the cooperative study of intracranial aneurysms and 
subarachnoid hemorrhage. Sec V, part I: natural history of subarachnoid 
hemorrhage, intracranial aneurysms, and arteriovenous malformation-based 
on 6,368 cases in the cooperative study. J Neurosurg (1966) 25:219–39. 
doi:10.3171/jns.1966.25.2.0219 
14. Eddleman CS, Hurley MC, Naidech AM, Batjer HH, Bendok BR. Endovascular 
options in the treatment of delayed ischemic neurological deficits due to 
cerebral vasospasm. Neurosurg Focus (2009) 26:E6. doi:10.3171/2008.11.
FOCUS08278 
15. Phillips TJ, Dowling RJ, Yan B, Laidlaw JD, Mitchell PJ. Does treatment of 
ruptured intracranial aneurysms within 24 hours improve clinical outcome. 
Stroke (2011) 42:1936–45. doi:10.1161/STROKEAHA.110.602888 
16. Bergui M, Bradac GB. Acute endovascular treatment of ruptured aneurysms 
in poor-grade patients. Neuroradiology (2004) 46(2):161–4. doi:10.1007/
s00234-003-1143-5 
17. Wong GK, Boet R, Ng SC, Chan M, Gin T, Zee B, et al. Ultra-early (within 24 
hours) aneurysm treatment after subarachnoid hemorrhage. World Neurosurg 
(2012) 77(2):311–5. doi:10.1016/j.wneu.2011.09.025 
18. Britz GW. ISAT trial: coiling or clipping for intracranial aneurysms? Lancet 
(2005) 366:783–5. doi:10.1016/S0140-6736(05)67190-5 
19. Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneu-
rysmal rebleeding before neurosurgical or neurological management. Stroke 
(2001) 32:1176–80. doi:10.1161/01.STR.32.5.1176 
20. Guo LM, Zhou HY, Xu JW, Wang Y, Qiu YM, Jiang JY. Risk factors related to 
aneurysmal rebleeding. World Neurosurg (2011) 76(3–4):292–8. doi:10.1016/j.
wneu.2011.03.025 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2016 Ibrahim Ali, Ashmawy, Eassa and Mansour. This is an open-access 
article distributed under the terms of the Creative Commons Attribution License (CC 
BY). The use, distribution or reproduction in other forums is permitted, provided the 
original author(s) or licensor are credited and that the original publication in this 
journal is cited, in accordance with accepted academic practice. No use, distribution 
or reproduction is permitted which does not comply with these terms.
